| Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961) |
|---|
| 08/01/2006 | US7084140 Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 07/27/2006 | WO2006077793A1 Antitumor agent |
| 07/27/2006 | US20060167013 5-methyl-2-(1-piperazinyl)benzenesulfonic acid; sodium channel blocking agent; cardiovascular disorder : ischemic heart disease, reperfusion, heart failure, hypertension, angina pectoris, arrhythmia, postsurgery complications |
| 07/27/2006 | US20060166976 Compositions and methods for treating or preventing convulsions or seizures |
| 07/27/2006 | CA2594482A1 Antitumor agent |
| 07/27/2006 | CA2593166A1 Mitotic kinesin inhibitors |
| 07/26/2006 | CN1809362A Substituted 1,4-diazepines and uses thereof |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/19/2006 | CN1264825C Dihydro-benzo [b][1,4] diazepin-2-one derivative as mglur 2 antagonists II |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | US7078398 Compositions and methods for treating or preventing convulsions or seizures |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/13/2006 | WO2006021833A3 Bisbenzamidines for the treatment of pneumonia |
| 07/12/2006 | CN1802187A Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/11/2006 | US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds |
| 07/11/2006 | US7074783 Analgesics; central nervous system disorders; asthma; rhinitis; antiarthritic agents; inflammatory bowel disorders |
| 07/06/2006 | WO2006070878A1 Carboxylic acid derivative or salt thereof |
| 07/06/2006 | WO2006046030A3 Tetracyclic indole derivatives as antiviral agents |
| 07/06/2006 | US20060148821 N,N-disubstituted diazocycloalkanes |
| 07/06/2006 | US20060148792 Substituted 1,4-benzodiazepines and uses thereof |
| 07/06/2006 | US20060148791 Glutamate receptor antagonists |
| 07/06/2006 | US20060148780 Diazepanes derivatives useful as ifa inhibitors |
| 07/05/2006 | EP1675838A1 1-benzoyl substituted diazepine derivatives as selective histamine h3 receptor agonists |
| 07/05/2006 | EP1280794B1 Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate |
| 07/04/2006 | US7071197 N,N-disubstituted diazocycloalkanes |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 06/29/2006 | WO2006067114A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/29/2006 | US20060142264 Novel amide derivatives |
| 06/29/2006 | CA2589367A1 Sulfonyl amino cyclic derivatives and use thereof |
| 06/28/2006 | EP1673347A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 06/28/2006 | EP1673059A2 Alkanol and cycloalkanol-amine derivatives and methods of their use |
| 06/28/2006 | EP1554276B1 Non-nucleoside reverse transcriptase inhibitors |
| 06/28/2006 | CN1261430C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067512 Substituted 1,4-benzodiazepines and uses thereof |
| 06/22/2006 | WO2006065826A2 Process to chiral beta amino acid derivatives by asymmetric hydrogenation |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | US20060135762 Preventing the deposits of amyloid protein, treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; {[carbamoyl]cycloalkyl}-N-(2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))- or (2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))-carboxamide |
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/20/2006 | US7064121 benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals |
| 06/15/2006 | US20060128955 Enantiomorph purity; chromatography |
| 06/15/2006 | US20060128695 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060123565 Para-phenylenediamine derivatives comprising a cyclic diaza group substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/08/2006 | WO2006059801A1 7-membered ring compound, process for producing the same, and medicinal use thereof |
| 06/08/2006 | US20060122169 Succinoylamino benzodiazepines as inhibitors of Abeta protein production |
| 06/08/2006 | CA2589638A1 7-membered ring compound and method of production and pharmaceutical application thereof |
| 06/07/2006 | EP1663996A1 (thio)carbamoyl-cyclohexane derivatives as d3/d2 receptor antagonists |
| 06/07/2006 | CN1784380A Novel bioisosteres of actinonin |
| 06/06/2006 | US7056921 Substituted chroman derivatives |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/01/2006 | WO2006057460A1 Nitrogen-containing fused ring compound and use thereof |
| 06/01/2006 | WO2005061467A3 Piperazine derivatives as bradykinin antagonists |
| 06/01/2006 | US20060116367 such as Biphenyl-2-carboxylic acid [3-chloro-4-(3-hydroxymethyl-4-methanesulfonyl-2,3,4,5-tetrahydrobenzo[e][1,4]diazepine-1-carbonyl)-phenyl]-amide, used for treating hypertension, congestive heart failure, ischemia, cirrhosis, renal failure, edema, stroke, thrombosis, coronary and renal vasospasm |
| 06/01/2006 | US20060115815 Method and compositions for identifying anti-hiv therapeutic compounds |
| 05/31/2006 | EP1660462A1 8-chloro-2,3-benzodiazepine derivatives |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1210332B1 Bleach boosting components, compositions and laundry methods |
| 05/31/2006 | CN1780821A Heterocyclic kinase inhibitors. |
| 05/30/2006 | US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053082 Neuroprotectants for treating epilepsy, stroke, Parkinson's disease, multiple sclerosis or amyotropic lateral sclerosis; 5-(3-methyl-4-amino or nitro-phenyl)-1,3-dioxolo[4,5-h][2,3]benzodiazepine; AMPA/cainate antagonistic effect; chemical intermediates |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2587040A1 Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke |
| 05/24/2006 | EP1019058B1 Pharmaceutical suspension comprising nevirapine hemihydrate |
| 05/23/2006 | CA2411766C Non-nucleoside reverse transcriptase inhibitors |
| 05/18/2006 | WO2006051851A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition |
| 05/18/2006 | WO2006051312A1 Gastrin and cholecystokinin receptor ligands |
| 05/18/2006 | WO2006010511A8 Method for producing 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1h)-on |
| 05/17/2006 | EP1656355A2 Piperazine derivatives and methods of use |
| 05/17/2006 | EP1656350A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 05/16/2006 | US7045516 Irritable bowel diosrders; gastrointestinal disorders; diarrhea |
| 05/11/2006 | WO2006049984A2 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 05/11/2006 | CA2585449A1 Novel [1,4]benzodiazepines as vasopressin v2 receptor antagonists |
| 05/10/2006 | EP1655300A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/10/2006 | EP1140786B9 Reductive alkylation of secondary amines with hydrosilane |
| 05/10/2006 | CN1771232A 11-phenyl-dibenzodiazepine derivatives as RXR-antagonists |
| 05/04/2006 | WO2006046030A2 Tetracyclic indole derivatives as antiviral agents |
| 05/04/2006 | WO2006032994A3 Muscarinic receptor antagonists |
| 05/04/2006 | CA2585084A1 Tetracyclic indole derivatives as antiviral agents |
| 05/03/2006 | EP1651623A2 Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/03/2006 | EP1099692B1 N,n-substituted cyclic amine derivatives |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 04/27/2006 | US20060089368 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1649871A1 Retroviral protease inhibitor combinations |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084662 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]-3,6-dihydro-2H-pyridine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder. |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/18/2006 | US7030214 Ureins derived from α, ω, diamino acids and process for their preparation |